Skip to main content

Table 4 Dimension 3: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the information and support.

From: Patient characteristics associated with differences in patients' evaluation of their general practitioner

  

100% positive assessments 1

0–49% positive assessments 2

  

Prev.(%)

PR

Adj. PR

95% CI

Prev.(%)

PR

Adj. PR

95% CI

Gender

(N = 25154)

Female

64.5

1

13

 

19.7

1

1

 
 

Male

64.4

1.00

0.95

0.93 – 0.97

19.1

0.97

1.05

0.99 – 1.11

Age (years)

(N = 25154)

18–24

52.4

1

13

 

25.0

1

1

 
 

25–29

55.5

1.06

1.04

0.97 – 1.12

23.7

1.03

0.96

0.84 – 1.10

 

30–34

57.8

1.10

1.10

1.03 – 1.18

22.9

1.00

0.90

0.79 – 1.02

 

35–39

60.2

1.15

1.18

1.11 – 1.26

22.5

1.01

0.84

0.74 – 0.94

 

40–44

61.0

1.16

1.23

1.15 – 1.32

22.6

1.00

0.79

0.70 – 0.90

 

45–49

62.1

1.19

1.28

1.19 – 1.37

21.1

0.90

0.71

0.61 – 0.81

 

50–54

63.9

1.22

1.34

1.26 – 1.43

18.8

0.88

0.61

0.53 – 0.70

 

55–59

68.8

1.31

1.47

1.37 – 1.57

17.2

0.74

0.54

0.47 – 0.63

 

60–64

70.9

1.35

1.52

1.42 – 1.62

16.2

0.67

0.51

0.44 – 0.59

 

65–69

75.1

1.43

1.61

1.50 – 1.72

13.1

0.58

0.41

0.35 – 0.49

 

70–74

75.6

1.44

1.62

1.52 – 1.73

14.4

0.53

0.46

0.39 – 0.54

 

75–79

71.7

1.37

1.56

1.45 – 1.67

15.1

0.51

0.47

0.40 – 0.56

 

80+

73.7

1.41

1.61

1.50 – 1.72

14.2

0.57

0.43

0.36 – 0.51

Further education (years)

(N = 24003)

None

65.9

1

13

 

19.1

1

1

 
 

Less than 2

65.1

0.95

1.02

0.98 – 1.06

20.6

1.08

1.03

0.92 – 1.15

 

2–4

64.1

0.85

0.99

0.96 – 1.01

19.5

1.02

1.01

0.93 – 1.08

 

5 or more

63.5

0.73

0.97

0.94 – 1.01

19.4

1.01

1.01

0.92 – 1.11

 

Undergoing education or other

63.9

0.84

1.02

0.97 – 1.07

18.7

0.97

0.91

0.79 – 1.06

Frequency of attendance (times per year)

(N = 25154)

0–1

63.9

1

13

 

22.5

1

1

 
 

2–3

63.1

0.99

1.01

0.98 – 1.05

20.8

0.93

0.89

0.81 – 0.98

 

4–5

63.8

1.00

1.03

1.00 – 1.07

18.9

0.84

0.79

0.71 – 0.86

 

6–7

65.7

1.03

1.09

1.05 – 1.13

19.4

0.86

0.75

0.68 – 0.83

 

8–9

66.0

1.03

1.11

1.06 – 1.16

18.5

0.82

0.70

0.62 – 0.79

 

10+

66.6

1.04

1.17

1.12 – 1.22

16.5

0.73

0.57

0.51 – 0.63

Duration of listing (years)

(N = 16745)

Less than 1

63.9

1

13

 

20.2

1

1

 
 

1–2

65.4

1.02

0.99

0.94 – 1.05

18.8

0.93

1.01

0.88 – 1.17

 

3–7

65.0

1.02

0.97

0.92 – 1.01

18.5

0.91

1.02

0.90 – 1.16

 

8–12

66.0

1.03

0.96

0.91 – 1.01

18.2

0.90

1.05

0.91 – 1.21

 

13+

68.2

1.07

0.98

0.93 – 1.03

17.0

0.84

1.01

0.88 – 1.16

Self-rated health

(N = 25154)

Excellent

71.2

1

13

 

15.7

1

1

 
 

Very good

66.9

0.94

0.89

0.87 – 0.92

17.2

1.10

1.21

1.09 – 1.35

 

Good

64.5

0.91

0.77

0.75 – 0.80

19.7

1.26

1.72

1.55 – 1.91

 

Fair

58.8

0.83

0.66

0.63 – 0.68

23.4

1.50

2.38

2.12 – 2.68

 

Poor

55.8

0.78

0.62

0.58 – 0.66

26.5

1.69

2.82

2.42 – 3.29

Chronic condition

(N = 24795)

No

63.7

1

13

 

20.2

1

1

 
 

Yes-KRTC

70.9

1.11

1.07

1.05 – 1.10

15.5

0.77

0.82

0.75 – 0.89

 

Yes-other or multiple

62.1

0.98

1.02

0.99 – 1.04

20.6

1.02

0.90

0.85 – 0.97

Chronic condition

(N = 16860)

None

63.7

1

13

 

20.2

1

1

 
 

K – Cardiovascular

73.0

1.15

1.09

1.05 – 1.13

14.3

0.71

0.80

0.71 – 0.91

 

R – Respiratory

65.5

1.03

1.06

1.01 – 1.11

19.5

0.97

0.91

0.79 – 1.04

 

T – Endocrine

70.7

1.11

1.08

1.03 – 1.13

15.0

0.74

0.79

0.68 – 0.92

 

C – Cancer

76.8

1.21

1.21

1.13 – 1.31

11.1

0.55

0.53

0.37 – 0.75

  1. Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self -rated health and clustering of frequency patients. Numbers in italics are used to indicate statistical significance.
  2. 1 Patients who marked 100% of the answered questions in one of the two most positive answering categories.
  3. 2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories.
  4. 3 Poisson regression with robust variance